Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms.

Siren MorkenSeppo W LangerAnna SundlövLene Weber VestermarkMorten LadekarlGeir Olav HjortlandJohanna B SvenssonElizaveta Mitkina TabaksblatTorjan Magne HaslerudJörg AssmusSönke DetlefsenAnne CouvelardAurel PerrenHalfdan Sorbye

Published in: British journal of cancer (2023)

ClinicalTrials.gov (NTC02248012).